Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study
Publication
, Conference
Szabolcs, P; Visani, G; Locatelli, F; Kleiner, G; Talano, J; Nemecek, ER; Kurtzberg, J
Published in: BONE MARROW TRANSPLANTATION
March 1, 2010
Duke Scholars
Published In
BONE MARROW TRANSPLANTATION
ISSN
0268-3369
Publication Date
March 1, 2010
Volume
45
Start / End Page
S18 / S18
Location
Vienna, AUSTRIA
Publisher
NATURE PUBLISHING GROUP
Conference Name
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting
Related Subject Headings
- Immunology
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Szabolcs, P., Visani, G., Locatelli, F., Kleiner, G., Talano, J., Nemecek, E. R., & Kurtzberg, J. (2010). Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study. In BONE MARROW TRANSPLANTATION (Vol. 45, pp. S18–S18). Vienna, AUSTRIA: NATURE PUBLISHING GROUP.
Szabolcs, P., G. Visani, F. Locatelli, G. Kleiner, J. Talano, E. R. Nemecek, and J. Kurtzberg. “Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study.” In BONE MARROW TRANSPLANTATION, 45:S18–S18. NATURE PUBLISHING GROUP, 2010.
Szabolcs P, Visani G, Locatelli F, Kleiner G, Talano J, Nemecek ER, et al. Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study. In: BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2010. p. S18–S18.
Szabolcs, P., et al. “Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study.” BONE MARROW TRANSPLANTATION, vol. 45, NATURE PUBLISHING GROUP, 2010, pp. S18–S18.
Szabolcs P, Visani G, Locatelli F, Kleiner G, Talano J, Nemecek ER, Kurtzberg J. Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study. BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2010. p. S18–S18.
Published In
BONE MARROW TRANSPLANTATION
ISSN
0268-3369
Publication Date
March 1, 2010
Volume
45
Start / End Page
S18 / S18
Location
Vienna, AUSTRIA
Publisher
NATURE PUBLISHING GROUP
Conference Name
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting
Related Subject Headings
- Immunology
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences